Khalid Abd-Elaziz
Dr. Khalid Abd-Elaziz is a specialist physician in clinical pharmacology and joined CTC Netherlands in 2024. Khalid has been principal and co-investigator in 80+ early phase clinical trials and is an all-round clinical pharmacologist with focus on design, execution, supervising, analysing, monitoring and reporting of clinical trials in healthy volunteers and patients. Khalid has especial interest in first-in-human and high risk phase I and phase II studies.